Cumberland Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-127,031
| Closed | -$7.92M | – | 60 |
|
|
2021
Q4 | $7.92M | Buy |
127,031
+4,485
| +4% | +$280K | 1.66% | 17 |
|
|
2021
Q3 | $7.25M | Buy |
122,546
+18,035
| +17% | +$1.07M | 1.68% | 18 |
|
|
2021
Q2 | $6.98M | Buy |
104,511
+5,311
| +5% | +$355K | 1.64% | 18 |
|
|
2021
Q1 | $6.26M | Buy |
99,200
+34,075
| +52% | +$2.15M | 1.55% | 20 |
|
|
2020
Q4 | $4.04M | Buy |
+65,125
| New | +$4.04M | 1.48% | 17 |
|
|
2020
Q2 | $3.66M | Buy |
+62,160
| New | +$3.66M | 1.38% | 19 |
|